Trial intelligence / Profile preview

Ziying Granules for Chronic Pelvic Pain After Pelvic Inflammatory Disease (Phase II)

CTR20254457Phase 2Active

Sponsor
Guangdong Fangsheng Rongke Pharmaceutical
Start
Jan 2026
Countries
1
01

Overview

A Phase 2 trial of Ziying Granules in chronic prostatitis (CP), sponsored by Guangdong Fangsheng Rongke Pharmaceutical. Started Jan 2026; status: active.

02

Drugs

Ziying Granules
03

Conditions

chronic prostatitis (CP)

Beyond the preview

Go deeper on CTR20254457.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20254457.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call